Roe DJ - Search Results

1

Reproducibility of the measurement of colonic proliferation using bromodeoxyuridine across laboratories.

Roe DJ, Alberts DS, Wargovich MJ, Bostick RM, Garewal HS, Einspahr J, Fosdick L, Ramsey L, Woods C, McGee DL. Roe DJ, et al. Cancer Epidemiol Biomarkers Prev. 1996 May;5(5):349-53. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 9162300

2

Usefulness of bone-marrow biopsy during induction therapy for acute myeloid leukemia.

Shamdas GJ, Garewal HS, Roe DJ. Shamdas GJ, et al. Among authors: roe dj. Lancet. 1992 Jan 18;339(8786):178. doi: 10.1016/0140-6736(92)90240-4. Lancet. 1992. PMID: 1346026 No abstract available.

3

Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer.

Taylor CW, Alberts DS, Peng YM, McCloskey TM, Matzner M, Roe DJ, Plezia PM, Grindey GB, Hamilton M, Seitz D. Taylor CW, et al. Among authors: roe dj. J Natl Cancer Inst. 1992 Dec 2;84(23):1798-802. doi: 10.1093/jnci/84.23.1798. J Natl Cancer Inst. 1992. PMID: 1433369 Clinical Trial.

4

Lack of ranitidine effects on cyclophosphamide bone marrow toxicity or metabolism: a placebo-controlled clinical trial.

Alberts DS, Mason-Liddil N, Plezia PM, Roe DJ, Dorr RT, Struck RF, Phillips JG. Alberts DS, et al. Among authors: roe dj. J Natl Cancer Inst. 1991 Dec 4;83(23):1739-42. doi: 10.1093/jnci/83.23.1739. J Natl Cancer Inst. 1991. PMID: 1770553 Clinical Trial.

5

Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimen.

Plezia PM, Alberts DS, Kessler JF, Berens PL, Chase JL, Roe DJ. Plezia PM, et al. Among authors: roe dj. J Pain Symptom Manage. 1990 Apr;5(2):101-8. doi: 10.1016/s0885-3924(05)80023-5. J Pain Symptom Manage. 1990. PMID: 2189929 Free article. Clinical Trial.

6

Clinical pharmacology of a novel diarylsulfonylurea anticancer agent.

Taylor CW, Alberts DS, Ketcham MA, Satterlee WG, Holdsworth MT, Plezia PM, Peng YM, McCloskey TM, Roe DJ, Hamilton M, et al. Taylor CW, et al. Among authors: roe dj. J Clin Oncol. 1989 Nov;7(11):1733-40. doi: 10.1200/JCO.1989.7.11.1733. J Clin Oncol. 1989. PMID: 2809686

7

Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosae in patients with Barrett's esophagus.

Garewal HS, Gerner EW, Sampliner RE, Roe D. Garewal HS, et al. Cancer Res. 1988 Jun 1;48(11):3288-91. Cancer Res. 1988. PMID: 3130189

8

Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration.

Alberts DS, Surwit EA, Peng YM, McCloskey T, Rivest R, Graham V, McDonald L, Roe D. Alberts DS, et al. Cancer Res. 1988 Oct 15;48(20):5874-7. Cancer Res. 1988. PMID: 3167842

9

Predictive model for plasma concentration-versus-time profiles of investigational anticancer drugs in patients.

Davis LE, Alberts DS, Plezia PM, Roe DJ, Griswold DP. Davis LE, et al. Among authors: roe dj. J Natl Cancer Inst. 1988 Aug 3;80(11):815-9. doi: 10.1093/jnci/80.11.815. J Natl Cancer Inst. 1988. PMID: 3392741

10

Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial.

Struck RF, Alberts DS, Horne K, Phillips JG, Peng YM, Roe DJ. Struck RF, et al. Among authors: roe dj. Cancer Res. 1987 May 15;47(10):2723-6. Cancer Res. 1987. PMID: 3552204 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters